Therma Bright Inc V.THRM

Little Unexpected But I’ll take it

[YoungBaklava]

Not sure how Thrm placed top 3 in life sciences for the top performers of 2022 tsc, but I'll take it I guess, and the fact that Fia mentions as recently as today about the acuvid moving its way through FDA shows his confidence in the product, which is also a positive. I was starting to think he was trying to overshadow Acuvid with these other product placements in the PRs, for cold sores etc, but for your company to get spotlight on yahoo finance for a good thing, I'm glad he publicly talked about his antigen test and not some other b.s thrm is working on, no one would publicize bad products in such a setting. Hopefully submission news is SOON enough.

Good on you Fia! IMHO GL TO ALL

[Watchman21]

Reading the release and TSX.com/Venture50. this was for the period of Jan 1, 2021-December 31, 2021...odd its 2022 Venture 50...should really be 2021 Venture 50, but alas it was recognized at the end of February 2022. All in all, this and the US Patent release from yesterday on 2 of THRM products (Therozap and Intercept) should demonstrate to shareholders this is a legitimate public firm.